project id: TCGA-SKCM; case submitter id: TCGA-WE-A8ZN; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.07; rna integrity number: 7.4; age at index: 57; days to birth: -20942; ethnicity: not hispanic or latino; gender: male; race: not reported; vital status: Alive; year of birth: 1952; age at diagnosis: 20942; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1794.0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1487; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-WE-A8ZN-06A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 4.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 11.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0;